This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including the ones under development on this web site.
Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.
Japan, February 9, 2006 - Astellas Pharma Inc. ("Astellas"; headquarters: Tokyo; President and CEO: Toichi Takenaka) today announced a following statement with regard to the news appeared on the front page of the day's morning edition of Asahi Shimbun titled as "Acquisition of Zepharma Inc."
"Although Astellas always studies every possible opportunity to maximize its business value, Astellas has made no concrete decision, including sell-off of Zepharma Inc. to Taisho Pharmaceutical Co, Ltd."
